IL-27 Antibody (N-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q8TAD2 |
---|---|
Clone Names | 3011505 |
Gene ID | 53342 |
---|---|
Other Names | Interleukin-17D, IL-17D, Interleukin-27, IL-27, IL17D, IL27 |
Target/Specificity | The synthetic peptide sequence used to generate the antibody AP1707a was selected from the N-term region of human L27 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | IL17D |
---|---|
Function | Induces expression of IL6, CXCL8/IL8, and CSF2/GM-CSF from endothelial cells. |
Cellular Location | Secreted. |
Tissue Location | Expressed preferentially in adipose, skeletal muscle and CNS. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
L27 is a cytokine that shares the sequence similarity with IL17. The treatment of endothelial cells with this cytokine has been shown to stimulate the production of other cytokines including IL6, IL8 and CSF2/ GM-CSF. The increased expression of IL8 induced by this cytokine was found to be NF-kappa B-dependent.
References
Clark, H.F., et al., Genome Res. 13(10):2265-2270 (2003).Starnes, T., et al., J. Immunol. 169(2):642-646 (2002).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.